Eurand makes new appointment
This article was originally published in Scrip
Executive Summary
The speciality pharmaceutical company Eurand (the Netherlands) has appointed Jean-Louis Anspach president of Eurand Pharmaceuticals. He was most recently executive vice-president of marketing at Solvay Pharmaceuticals, which was acquired by Abbott Laboratories in February.